Replay
Toggle
Menu
Platforms
Products
Team
News
Latest news
Filter By:
media
news
View All
Cristian Massacesi, M.D., Appointed to Replay Board of Directors
Read More
25.05.2023
– NEWS
Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer
Read More
18.05.2023
– NEWS
Cell and gene therapy biotech creator Replay plucks Allogene CMO Arun Balakumaran to lead clinical trials
↳
endpts.com
18.05.2023
– MEDIA
Ask the Experts with Matthew Mulvey: What is “Big DNA”?
Read More
25.04.2023
– NEWS
Rare Disease Day 2023: In conversation with Alex Silver
Read More
28.02.2023
– NEWS
KKR-backed Replay and MD Anderson form new product company Syena to pioneer first-in-class TCR-NK cell therapy
Read More
14.02.2023
– NEWS
Replay Bio partners with MD Anderson’s Katy Rezvani, heads to clinic with new TCR NK cell company
↳
endpts.com
14.02.2023
– MEDIA
Replay targets genetic brain disorders with new gene therapy company, Kaleibe, utilising big DNA HSV technology
Read More
14.12.2022
– NEWS
Replay receives $1.5 million grant for its hypoimmunogenic technology platform
Read More
28.11.2022
– NEWS
Maker of new gene therapy vector launches its second company, looking to zero in on rare skin conditions
↳
endpts.com
21.11.2022
– MEDIA
Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseases
Read More
21.11.2022
– NEWS
Under hub-and-spoke biotech, serial founders launch new startup hoping to make gene therapies for the eye
↳
endpts.com
31.10.2022
– MEDIA
Replay launches its first HSV gene therapy company, Eudora, focused on retinal eye disease
Read More
31.10.2022
– NEWS
Replay establishes distinguished Scientific Advisory Board of genomic medicine and cell therapy experts
Read More
17.10.2022
– NEWS
Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA
Read More
29.07.2022
– NEWS
KKR backs medicine start-up as private equity pushes into sector
↳
FT.com
28.07.2022
– MEDIA
Pfizer, BMS vet hits Replay with $55M seed financing, 'Big DNA' ambitions
↳
fiercebiotech.com
27.07.2022
– MEDIA
Replay Launches with $55 Million Seed to Transform Genomic Medicine with Interlinking Technology Platforms
↳
genengnews.com
25.07.2022
– MEDIA
With AAV alternative and DNA writing tech, a new hub-and-spoke startup wants to ‘democratize’ gene therapies
↳
endpts.com
25.07.2022
– MEDIA
Join Replay
Help us to author the future of genomic medicine
Open positions